Correlation Between Qualigen Therapeutics and Bristol Myers
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Bristol Myers Squibb, you can compare the effects of market volatilities on Qualigen Therapeutics and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Bristol Myers.
Diversification Opportunities for Qualigen Therapeutics and Bristol Myers
-0.27 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Qualigen and Bristol is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Bristol Myers go up and down completely randomly.
Pair Corralation between Qualigen Therapeutics and Bristol Myers
Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Bristol Myers. In addition to that, Qualigen Therapeutics is 3.72 times more volatile than Bristol Myers Squibb. It trades about -0.18 of its total potential returns per unit of risk. Bristol Myers Squibb is currently generating about -0.2 per unit of volatility. If you would invest 5,165 in Bristol Myers Squibb on January 25, 2024 and sell it today you would lose (266.00) from holding Bristol Myers Squibb or give up 5.15% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Qualigen Therapeutics vs. Bristol Myers Squibb
Performance |
Timeline |
Qualigen Therapeutics |
Bristol Myers Squibb |
Qualigen Therapeutics and Bristol Myers Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Qualigen Therapeutics and Bristol Myers
The main advantage of trading using opposite Qualigen Therapeutics and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Bristol Myers vs. Silver Spike Investment | Bristol Myers vs. Alkermes Plc | Bristol Myers vs. Eagle Pharmaceuticals | Bristol Myers vs. Evotec SE ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |